Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation... (John Mendelsohn M.D. President ...)

Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium

Date:4/8/2009

>John Mendelsohn, M.D., President, M.D. Anderson Cancer Center;

Donald W. Rucker, M.D., VP and Chief Medical Officer, Siemens Medical Solutions USA;

Charles L. Sawyers, M.D., Chairman of Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center.

Damon Runyon Clinical Investigators, a select group of innovative physician-scientists funded through the Damon Runyon Clinical Investigator Award program, will discuss their groundbreaking translational research, covering a broad range of topics including the latest work in cancer prevention, biomarkers, cancer stem cells and immunotherapy.

Presenting Damon Runyon Clinical Investigators include:

Jeremy N. Rich, M.D., Chairman, Department of Stem Cell Biology and Regenerative Medicine, Cleveland Clinic - Cancer Stem Cells
Maura L. Gillison, M.D., Ph.D., Professor of Medicine and Chair of Cancer Research, Ohio State University - HPV and Head and Neck Cancer
Joseph A. Califano, III, M.D., Professor of Otolaryngology, Johns Hopkins University School of Medicine - Using Bodily Fluids for Early Detection of Cancers
Cassian Yee, M.D., Associate Member, Clinical Research Program in Immunology, Fred Hutchinson Cancer Research Center'/>"/>

SOURCE Damon Runyon Cancer Research Foundation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. NIH grant to strengthen IU and Purdue program to educate physician-scientists
2. NYP/Weill Cornell physician-scientists present latest cancer findings at ASCO meeting
3. NYP/Columbia physician-scientists present at ASCO 44th annual meeting
4. BWF awards $11.2 million to support physician-scientists
5. NewYork-Presbyterian/Columbia physician-scientists present at ACCs 57th Annual Scientific Session
6. Best-selling authors and physicians from NYP/Weill Cornell discuss diet, surgery and bone health
7. Boston Scientific to Webcast Conference Call Discussing First Quarter Financial Results
8. CVS Caremark Discusses Role of Health IT to Optimize Pharmacy Health Care
9. HCSC Discusses the Controversial ICD-10 Transition at the 2009 HIMSS Conference
10. Surgeons to Observe and Discuss Live Eye Surgery Friday Night in San Francisco
11. AMERIGROUP Corporation to Discuss First Quarter Earnings on May 1

Post Your Comments:

(Date:11/27/2009)...ov.27/PRNewswire-FirstCall/--TheGymboreeCorporatio...willpresentattheNASDAQOMX23rdInvestorProgram,which...esday,December2,2009,at11:45a.m.GMT. ,, Toliste...ationovertheInternet,pleaselogontowww.gymboree.com...storandMediaRelations"andthen"ConferenceCalls&...

(Date:11/27/2009)...INE,France,Nov.27/PRNewswire/--TeamGarmin-Slipstre...dtoethicalsportinganddevelopingthenextgenerationof...mGarmin-TransitionswiththeadditionofTransitionsOpt...world,sleadingmanufacturerofadaptiveeyewear,offeri...selectionofspectaclelensessuchasTransitionslensesa...

(Date:11/27/2009)... XenaCare Holdings has announced that it has be...n, one of the largest nonprofit organizations dedi...ation. , Delray Beach, FL...nc. (OTCBB: XCHO), a company specializing in the m...hcare products, has announced today that is has be...

(Date:11/27/2009)... unprecedented medical, economic burdens, study pr...ws) -- The number of people with diabetes in the U...5 years, a new study predicts. , That would bri...with the disease, up from 23.7 million today. , ,...th diabetes will triple, the study also warns, ris...

(Date:11/27/2009)... Voyant Health™ announced today that Spec...its TraumaCad Enterprise orthopedic templating sol... , (PRWEB) November 27, 20...ectrum Health (Grand Rapids, Michigan) has license...olution and its TraumaCad Extend workflow solution...

Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2 Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3 Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2 Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3 Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4 Health News:Diabetes Cases Expected to Double in 25 Years 2 Health News:Diabetes Cases Expected to Double in 25 Years 3 Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2 Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3

[0] The Gymboree Corporation to Present at NASDAQ OMX 23rd Investor Program [0] Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor [0] XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation [0] Diabetes Cases Expected to Double in 25 Years [0] Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend

..., May 7 Conseco, Inc. (NYSE: CNO ),today reporte...t a new quarterly sales record with an increase of...ieur said. "This performance included,an 11% incre...surance Group,s sales declined 21%, but specified ...

...is common in the aggressive form of the disease, r...althDay News) -- For the first time, a gene linked... has been identified, researchers report. , "This ...ldhood Cancer Research at The Children,s Hospital ...

...ON, May 7 -- Shire plc(LSE: SHP, Nasdaq: SHPGY), ...esented today at a major scientific meeting findin...NIV, a selective alpha-2A-agonist. This compound,...(ADHD)., The data demonstrated that INTUNIV showed...

...ct Examination Finds Serious Violations in Long-Te... Acting Insurance,Commissioner Joel Ario today ann...ich was necessary due to a pattern of consumer har...2.3 million fine and an additional $30,million in ...

....3 million fine, CARMEL, Ind., May 7 Conseco, In...g state insurance regulators and two of,its insura...(CSHI) Company,and Bankers Life and Casualty Compa...e claims practices and,procedures, complaint handl...

...y 7 Longer life expectancy, greater,interest in s...ccess are,all factors fueling growth in sales of o...ted $68.4 billion in 2007 sales, with a 3.9% CAGR ... BTC and Other Growth Trends, this market should e...

Conseco Reports First Quarter Results Gene Variation Linked to Neuroblastoma, a Childhood Cancer Shire investigational nonstimulant INTUNIV showed significant efficacy in reducing ADHD symptoms Insurance Department Fines Conseco Under Pennsylvania-Led, Multi-State Agreement Conseco Reaches Settlement of Multistate Market Conduct Examination Self-Medication One of Many Factors Driving OTC Drug Market Past $80 Billion by 2012

(Date:11/26/2009)...hAfrica,Nov.26/PRNewswire/--The2009Frost&Sulli...rmaceuticalMarketispresentedtoCiplaMedproSouthAfri...-bin/prnh/20081117/FSLOGO ) ,, FortheCompanyoft...kCiplaMedpro,sperformanceagainstkeycompetitors:gro...usinessprocesses,productsand/ortechnologiesandlead...

(Date:11/25/2009)....25/PRNewswire-FirstCall/--AmericanScientificResou...announcethattheyhaveopenedaregionalmarketingandpro...hasbeenabletosecurealocationabroad,providinganesse...tandfuturehealthandsafetyproductsforchildrenandadu...anyhousesinventoryinthestateofOhiowheretheywillals...

(Date:11/25/2009)....25/PRNewswire-FirstCall/--Hologic,Inc.(Hologicort...cturerandsupplierofpremiumdiagnostics,medicalimagi...ealthcareneedsofwomen,isusingtheannualmeetingofthe...PlaceinChicago,November29throughDecember3,2009tohi...osticmammographyworkstationsoftware. ,, TheHolo...

[0] Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market [0] American Scientific Resources Inc. Opens Shanghai Location [0] New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity

...of patients with multiple sclerosis, remained re...l FTY720,- New data demonstrate 89% of patients fr...used by MS - three years after starting treatment,...disability, affects 2.5 million people wo...latory filings planned before end of 2009 in US an...

...tes potential for once daily oral d...neration MEK inhibitor, RDEA436, to enter Phase 1 ...2008 -, SAN DIEGO, April 15 Ardea Biosciences, I... presented demonstrating the,potent activity and f...mitogen-activated ERK kinase (MEK) inhibitor famil...

Other Medicine Technology:FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 2 FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 3 FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 4 FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 5 FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 6 Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors 2 Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors 3 Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors 4

FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors

...ic protein produced and stored in somatotrophs in ...the pituitary into the bloodstream in a pulsatile ...c somatostatin (SS) and GH-releasing factor (GHRF)...rs to be regulated by somatostatin, while the ampl...

...ocorticoid produced by the human adrenal cortex. I...y to corticosteroid-binding globulin (CBG), with t...ts on specific intracellular receptors with effect...e function, glucose counter-regulation, vascular t...

...F-I or somatomedin C) is a 7.6 kDa peptide produce...gen of cellular proliferation, exerting its action...n the circulation, IGF-I is bound to IGF-binding p...ions of IGF-I by modulating the interaction of IGF...

Medicine Products:

Bioactive hGH ELISA Test Cortisol RIA Test IGF-I IRMA Test (With Extraction)IGF-I IRMA Test (Non-Extraction)

Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation...(John Mendelsohn M.D. President ...),Health